Publication Type:

Journal Article


Journal of Clinical Microbiology, Volume 49, Number 12, p.4374-4376 (2011)



16S, abscess drainage, acid fast bacterium, Actinomycetales, Actinomycetales Infections, adult, amikacin, amoxicillin, ampicillin, Anti-Bacterial Agents, antibiotic sensitivity, article, Bacterial, bacterium identification, bacterium isolation, Brain, brain abscess, brain edema, Brevibacterium, Brevibacterium casei, case report, cefotaxime, ceftriaxone, chloramphenicol, ciprofloxacin, clinical examination, craniotomy, daptomycin, debridement, dexamethasone, diagnostic error, DNA, doxycycline, ethambutol, focal epilepsy, gentamicin, genus, Gram staining, headache, histopathology, hospitalization, human, Humans, imipenem, immunocompetence, intracranial tuberculoma, isoniazid, linezolid, Magnetic Resonance Imaging, male, mannitol, meropenem, minimum inhibitory concentration, Molecular Sequence Data, nuclear magnetic resonance imaging, nuclear magnetic resonance spectroscopy, nucleotide sequence, paresthesia, penicillin G, priority journal, pyrazinamide, Ribosomal, rifampicin, RNA, RNA 16S, sequence analysis, treatment outcome, unconsciousness, vancomycin, vomiting


Coryneform bacteria belonging to the genus Brevibacterium have emerged as opportunistic pathogens. Of the nine known species of Brevibacterium isolated from human clinical samples, Brevibacterium casei is the most frequently reported species from clinical specimens. We report the first case of B. casei brain abscess in an immunocompetent patient successfully treated by surgery and antimicrobial therapy. Copyright © 2011, American Society for Microbiology. All Rights Reserved.


cited By (since 1996)1

Cite this Research Publication

V. Aa Kumar, Augustine, Db, Panikar, Dc, Nandakumar, Aa, Dinesh, K. Ra, Karim, Sa, and Philip, Rb, “Brevibacterium casei as a cause of brain abscess in an immunocompetent patient”, Journal of Clinical Microbiology, vol. 49, pp. 4374-4376, 2011.